J 2019

Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

BLANCO, Elena, Martin PEREZ-ANDRES, Sonia ARRIBA-MENDEZ, Cristina SERRANO, Ignacio CRIADO et. al.

Základní údaje

Originální název

Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

Autoři

BLANCO, Elena (724 Španělsko), Martin PEREZ-ANDRES (724 Španělsko), Sonia ARRIBA-MENDEZ (724 Španělsko), Cristina SERRANO (724 Španělsko), Ignacio CRIADO (724 Španělsko), Lucia DEL PINO-MOLINA (724 Španělsko), Susana SILVA (620 Portugalsko), Ignacio MADRUGA (724 Španělsko), Marina BAKARDJIEVA (203 Česká republika), Catarina MARTINS (620 Portugalsko), Ana SERRA-CAETANO (620 Portugalsko), Alfonso ROMERO (724 Španělsko), Teresa CONTRERAS-SANFELICIANO (724 Španělsko), Carolien BONROY (56 Belgie), Francisco SALA (724 Španělsko), Alejandro MARTIN (724 Španělsko), Jose Maria BASTIDA (724 Španělsko), Felix LORENTE (724 Španělsko), Carlos PRIETO (724 Španělsko), Ignacio DAVILA (724 Španělsko), Miguel MARCOS (724 Španělsko), Tomas KALINA (203 Česká republika), Marcela VLKOVÁ (203 Česká republika, domácí), Zita CHOVANCOVÁ (203 Česká republika, domácí), Ana Isabel CORDEIRO (620 Portugalsko), Jan PHILIPPE (56 Belgie), Filomeen HAERYNCK (56 Belgie), Eduardo LOPEZ-GRANADOS (724 Španělsko), Ana E. SOUSA (620 Portugalsko), Mirjam VAN DER BURG (528 Nizozemské království), Jacques J. M. VAN DONGEN (528 Nizozemské království) a Alberto ORFAO (724 Španělsko, garant)

Vydání

Journal of allergy and clinical immunology, New York, Mosby-Elsevier, 2019, 0091-6749

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 10.228

Kód RIV

RIV/00216224:14110/19:00112958

Organizační jednotka

Lékařská fakulta

UT WoS

000485222300025

Klíčová slova anglicky

Immunodeficiency; primary antibody deficiency; selective IgA deficiency; common variable immunodeficiency; immunophenotyping; immunoglobulins; immunoglobulin subclasses; memory B cells; plasma cells; flow cytometry; diagnosis; classification

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 17. 2. 2020 10:35, Mgr. Tereza Miškechová

Anotace

V originále

Background: Predominantly antibody deficiencies (PADs) are the most prevalent primary immunodeficiencies, but their B-cell defects and underlying genetic alterations remain largely unknown. Objective: We investigated patients with PADs for the distribution of 41 blood B-cell and plasma cell (PC) subsets, including subsets defined by expression of distinct immunoglobulin heavy chain subclasses. Methods: Blood samples from 139 patients with PADs, 61 patients with common variable immunodeficiency (CVID), 68 patients with selective IgA deficiency (IgAdef), 10 patients with IgG subclass deficiency with IgA deficiency, and 223 age matched control subjects were studied by using flow cytometry with EuroFlow immunoglobulin isotype staining. Patients were classified according to their B-cell and PC immune profile, and the obtained patient clusters were correlated with clinical manifestations of PADs. Results: Decreased counts of blood PCs, memory B cells (MB Cs), or both expressing distinct IgA and IgG subclasses were identified in all patients with PADs. In patients with IgAdef, B-cell defects were mainly restricted to surface membrane (sm)IgA(+) PCs and MBCs, with 2 clear subgroups showing strongly decreased numbers of smIgA(+) PCs with mild versus severe smIgA(+) MBC defects and higher frequencies of nonrespiratory tract infections, autoimmunity, and affected family members. Patients with IgG subclass deficiency with IgA deficiency and those with CVID showed defects in both smIgA(+) and smIgG(+) MBCs and PCs. Reduced numbers of switched PCs were systematically found in patients with CVID (absent in 98%), with 6 different defective MBC (and clinical) profiles: (1) profound decrease in MBC numbers; (2) defective CD27(+) MBCs with almost normal IgG(3)(+) MBCs; (3) absence of switched MBCs; and (4) presence of both unswitched and switched MBCs without and; (5) with IgG(2)(+) MBCs; and (6) with IgA(1)(+) MBCs. Conclusion: Distinct PAD defective B-cell patterns were identified that are associated with unique clinical profiles.